Home » Topics » Disease categories and therapies » Urology

Urology
RSS

Positive preliminary results reported for extended-use clinical trial of RenaGel

July 3, 1998

Nippon Shinyaku discovers new treatment for urinary incontinence

June 12, 1998

ET antagonist protects against ciclosporin-induced nephrotoxicity in rats

June 11, 1998

New and established treatments for BPH reviewed at AUA

June 10, 1998

Urinary reflux product enters phase III

June 9, 1998

Dornier's BPH device approved by FDA

June 9, 1998

LU-302872, an orally active ETA/ETB antagonist for the treatment of BPH

June 5, 1998

Synthelabo discloses new agents for urinary incontinence

June 5, 1998

Ditropan XL effectively controls urge incontinence in phase III trial

June 5, 1998

Celsion to evaluate BPH system in phase I trial

June 3, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
BMS-Hengrui deal strikes panic in Washington
BioWorld
On the heels of the multibillion-dollar licensing deal between Bristol Myers Squibb Co. and Jiangsu Hengrui Pharmaceuticals Co. Ltd., Chairman John Moolenaar...
Initial data hint that US MFN pricing is hitting access in Europe
BioWorld
There are initial signs that President Donald Trump’s most-favored nation (MFN) policy may be further delaying access to new drugs in Europe, as companies hold...